Targeting the Endocannabinoid System within Islets of Langerhans to Protect against Immune Destruction.

Project Information

DIRECtA

Grant agreement ID: 748749

DOI

10.3030/748749

Project closed

EC signature date 6 March 2017

Start date 3 January 2018

End date 2 January 2020

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 158 121,60

EU contribution

€ 158 121,60

Coordinated by

FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

THE ATYPICAL CANNABINOID ABN-CBD REDUCES INFLAMMATION AND PROTECTS LIVER, PANCREAS AND ADIPOSE TISSUE IN A MOUSE MODEL OF PREDIABETES AND NON-ALCOHOLIC FATTY LIVER DISEASE

Author(s): Silvana Y. Romero-Zerbo, María García-Fernández, Vanesa Espinosa-Jimenez, Macarena Pozo-Morales, Alejandro Escamilla-Sánchez, Lourdes Sánchez-Salido, Estrella Lara, Nadia Cobo-Vuilleumier, Alex Rafacho, Gabriel Olveira, Gemma Rojo-Martínez, Benoit R. Gauthier, Isabel González-Mariscal and Francisco J. Bermúdez-Silva
Published in: Frontiers in Endocrinology, 2020, ISSN 1664-2392
Publisher: FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2020.00103